Intensive Care News and Research

RSS

Immunotherapy, steroids restore heart function in children with COVID-related multi-system inflammatory syndrome

Treatment with antibodies purified from donated blood - immune globulin therapy - and steroids restored heart function in the majority of children with COVID-related multi-system inflammatory syndrome, according to new research published yesterday in Circulation, the flagship journal of the American Heart Association.

19 May 2020

The use of rheumatoid arthritis drug sarilumab in severe COVID-19 pneumonia

A new study published on the preprint server medRxiv* in May 2020 reports the beneficial effects of the monoclonal antibody sarilumab in severe COVID-19 pneumonia.

19 May 2020

Do parasites protect against SARS-CoV-2?

The world has rarely seen such a readily transmissible infection as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) over the last century. Within five months, the virus has created a Tsunami of COVID-19 positive cases, comprising almost 4.88 million people and causing 322,000 deaths.

19 May 2020

Sleep apnea may increase the risk of severe COVID-19, say researchers

An analysis conducted by researchers at the University of Turku and Turku University Hospital in Finland has suggested that obstructive sleep apnea (OSA) may be a risk factor for severe coronavirus disease 2019 (COVID-2019).

19 May 2020

Steroids and immunotherapy improve outcomes in children with COVID-related multi-system inflammatory syndrome

19 May 2020

Study highlights need to focus on medications that address clot formation

Earlier this week, the BBC reported that one-third of COVID-19 patients developed dangerous blood clots.

19 May 2020

Testing is lifesaving, concludes US study

One of the most critical steps in controlling a pandemic disease, which has a significant mortality rate, is testing for the disease. Though this may appear relevant and obvious, its ability to forecast mortality in the current COVID-19 pandemic has not been tested.

18 May 2020

Global study to test whether antimalaria drug can prevent COVID-19 in health-care workers

With $9 million in philanthropic support, an international group of physicians and scientists is establishing a research network to evaluate promising therapies for COVID-19.

18 May 2020

Cigarette smoke spurs the lungs to make more SARS-CoV-2 receptors

New research from CSHL scientists suggests that cigarette smoke spurs the lungs to make more ACE2 (angiotensin-converting enzyme 2), the protein that the coronavirus responsible for COVID-19 grabs and uses to enter human cells.

18 May 2020

Study aims to identify markers that predict how COVID-19 affects patients

COVID-19 is the UK's largest public health crisis since World War II. There is an urgent need to identify why some patients with the virus do very well whereas others need to be admitted to intensive care and may die from the disease.

18 May 2020

Tourists, beware: Foreign visitors’ travel health insurance might exclude pandemics

It was evident that the fever, nausea and loss of appetite Vlastimil Gajdoš felt on his wedding day was not a mere case of cold feet.

18 May 2020

COVID-19 may lead to thrombosis in the lungs and subsequently multi organ failure

COVID-19, the disease caused by SARS-CoV-2, not only may lead to severe pneumonia but also to thrombosis in the lungs and, subsequently, to multi organ failure involving kidneys, liver and pancreas.

18 May 2020

Researchers are developing advanced measures to fight against COVID-types contagions

A research team from the University of Valencia, led by the professor of the Department of Computer Science Pedro Morillo, is developing a project to improve protection against infections in areas of high availability of health centres.

18 May 2020

Kawasaki disease outbreak in children with COVID-19

The ongoing COVID-19 pandemic has marched its way to almost all parts of the world, with hundreds of thousands of deaths and over 4.5 million cases as of May 15, 2020. One saving grace has been the apparent sparing of children, though the mortality in older people is quite high.

17 May 2020

Researchers investigate safety of convalescent plasma for COVID-19

The current pandemic of COVID-19 seems to be slowing down in various parts of the world, but is far from controlled, as incidence rates rise in new regions. In the absence of an effective vaccine or therapeutic drug, scientists have relied on supportive medical care to treat the sick.

17 May 2020

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

15 May 2020

Antiviral drug can help accelerate recovery of COVID-19 patients, study shows

An international team of researchers led by Dr. Eleanor Fish, emerita scientist at the Toronto General Hospital Research Institute, University Health Network, and professor in the University of Toronto's Department of Immunology, has shown for the first time that an antiviral drug can help speed up the recovery of COVID-19 patients.

15 May 2020

New technology can be used for remote monitoring of individuals with suspected COVID-19

Agência FAPESP – Developed by Biologix, a startup headquartered in São Paulo, Brazil, a sleep apnea home diagnostic and monitoring system based on the Internet of Things can be used for the remote monitoring of individuals with suspected COVID-19 or mild symptoms of the disease.

15 May 2020

Study: Over 28 million elective operations could be cancelled due to COVID-19 pandemic

Over 28 million elective surgeries across the globe could be cancelled as a result of the COVID-19 pandemic – leading to patients facing a lengthy wait for their health issues to be resolved, a new study reveals.

15 May 2020

Chasing the elusive dream of a COVID cure

Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure for the disease that has killed nearly 260,000 people remains a long way off — and might never arrive.

15 May 2020

Intensive Care News and Research

Immunotherapy, steroids restore heart function in children with COVID-related multi-system inflammatory syndrome

The use of rheumatoid arthritis drug sarilumab in severe COVID-19 pneumonia

Do parasites protect against SARS-CoV-2?

Sleep apnea may increase the risk of severe COVID-19, say researchers

Steroids and immunotherapy improve outcomes in children with COVID-related multi-system inflammatory syndrome

Study highlights need to focus on medications that address clot formation

Testing is lifesaving, concludes US study

Global study to test whether antimalaria drug can prevent COVID-19 in health-care workers

Cigarette smoke spurs the lungs to make more SARS-CoV-2 receptors

Study aims to identify markers that predict how COVID-19 affects patients

Tourists, beware: Foreign visitors’ travel health insurance might exclude pandemics

COVID-19 may lead to thrombosis in the lungs and subsequently multi organ failure

Researchers are developing advanced measures to fight against COVID-types contagions

Kawasaki disease outbreak in children with COVID-19

Researchers investigate safety of convalescent plasma for COVID-19

COVID-19 patients at high risk for developing complications associated with blood clots

Antiviral drug can help accelerate recovery of COVID-19 patients, study shows

New technology can be used for remote monitoring of individuals with suspected COVID-19

Study: Over 28 million elective operations could be cancelled due to COVID-19 pandemic

Chasing the elusive dream of a COVID cure

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News